Inhibition of release of tumor necrosis factor-α from human vascular tissue and smooth muscle cells by glucocorticoids

Critical Care Medicine

Volumn 25, Issue 3, 1997, Pages 519-522

  Newman, Walter H ^a   Zhang, Li Ming ^a   Leeper Woodford, Sandra K ^a   Shaker, Isaam J ^a   Erceg, Stefan K ^a   Castresana, Manuel R ^a  

^a MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

blood vessels; glucocorticoids; smooth muscle cells; TNF

Indexed keywords

DEXAMETHASONE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GLUCOCORTICOID; METHYLPREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERNAL MAMMARY ARTERY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SAPHENOUS VEIN; SMOOTH MUSCLE FIBER; VASCULAR TISSUE;

CELLS, CULTURED; DEXAMETHASONE; DRUG EVALUATION, PRECLINICAL; GLUCOCORTICOIDS; HUMANS; LIPOPOLYSACCHARIDES; MAMMARY ARTERIES; MUSCLE, SMOOTH, VASCULAR; SAPHENOUS VEIN; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030896302     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199703000-00023     Document Type: Article

References (26)

1. Strieter RM, Kunkel SL, Bone RC: Role of tumor necrosis factor-α in disease states and inflammation. Crit Care Med 1993; 21:8447-8463
2. Tracey KJ, Cerami A: Tumor necrosis factor: An updated review of its biology. Crit Care Med 1993; 21:8415-8422
3. Han J, Buetler B, Huez G: Complex regulation of tumor necrosis factor mRNA turnover in lipopolysaccharide-activated macrophages. Biochim Biophys Acta 1991; 1090:22-28
4. Vilcek J, Lee TH: Tumor necrosis factor: New insights into the molecular mechanisms of its multiple actions. J Biol Chem 1991; 266:7313-7316
5. Han J, Brown T, Beutler B: Endotoxin-responsive sequences control cachectin/ tumor necrosis factor biosynthesis at the translational level. J Exp Med 1990; 171:465-475
6. Han J, Thompson P, Beutler B: Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. J Exp Med 1990; 172:391-394
7. Dunham DM, Arkins S, Edwards CKI, et al: Role of interferon-γ in counteracting the suppressive effects of transforming growth factor-β2 and glucocorticoids on the production of tumor necrosis factor alpha. J Leukocyte Biol 1990; 48: 473-481
8. Heidenreich S, Kubis T, Schmidt M, et al: Glucorticoid-induced alterations of monocyte defense mechanisms against Candida albicans. Cell Immunol 1994; 157:320-327
9. Newman WH, Zhang LM, Leeper-Woodford SK, et al: Human blood vessels release tumor necrosis factor alpha from a smooth muscle cell source. Crit Care Med 1996; 24:294-297
10. Bradford MM: A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 1976; 72:248-254
11. Flick DA, Gifford GE: Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. Immunol Meth 1984; 68:167-175
12. Levine B, Kalman J, Mayer L, et al: Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 323: 236-241
13. Scuderi P, Lam KS, Ryan KJ, et al: Raised serum levels of tumor necrosis factor in parasitic infections. Lancet 1986; ii:1364-1365
14. Leeper-Woodford SK, Fisher BJ, Sugerman HJ, et al: Pharmacologic reduction in tumor necrosis factor activity of pulmonary alveolar macrophages. Am J Respir Cell Mol Biol 1993; 8:169-175
15. Duhravec DB, Spriggs DR, Mannick JA, et al: Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor-α. Proc Natl Acad Sci USA 1990; 87:6758-6761
16. Warner SJC, Libby P: Human vascular smooth muscle cells: Target for and source of tumor necrosis factor. J Immunol 1989; 142:100-109
17. Barath P, Fishbein MC, Cao J, et al: Detection and localization of tumor necrosis factor in human atheroma. Am J Cardiol 1990; 65:297-302
18. Barath P, Fishbein MC, Cao J, et al: Tumor necrosis factor gene expression in human vascular intimal smooth muscle cells detected by in situ hybridization. Am J Pathol 1990; 137:503-509
19. Rus HG, Niclescu F, Vlaicu R: Tumor necrosis factor-alpha in human arterial wall with atherosclerosis. Atherosclerosis 1991; 89:247-254
20. Hansson GK, Jonasson L, Seifert PS, et al: Immune mechanisms in atherosclerosis. Arteriosclerosis 1989; 9: 567-578
21. Stein O, Shiloni E, Stein Y: Effect of TNF on triacylglycerol in cultured vascular smooth muscle cells. Biochim Biophys Acta 1991; 1082:33-36
22. Morisaki N, Xu QP, Koshikawa T, et al: Tumour necrosis factor-α can modulate the phenotype of aortic smooth muscle cells. Scand J Clin Lab Invest 1993; 53:347-352
23. Hollenberg SM, Cunnion RE, Parrillo JE: The effect of tumor necrosis factor on vascular smooth muscle: In vitro studies using rat aortic rings. Chest 1991; 100:1133-1137
24. Couffinhal T, Duplaa C, Labat L, et al: Tumor necrosis factor-α stimulates ICAM-1 expression in human vascular smooth muscle cells. Arteriosclerosis and Thrombosis 1993; 13:407-414
25. Goldblum SE, Ding X, Campbell-Washington J: TNF-α induces endothelial cell F-actin depolymerization, new actin synthesis, and barrier dysfunction. Am J Physiol 1993; 264:C894-C895
26. Ikuta S, Kirby JA, Shenton BK, et al: Human endothelial cells: Effect of TNF-alpha on peripheral blood mononuclear cell adhesion. Immunology 1991; 73: 71-76